Financial IT is the online and print resource for FinTech market analysis. We provide a unique and valuable forum for people involved in the change process to learn and exchange ideas and knowledge – as technology cements its pivotal role in supporting the financial markets. Financial IT also reflects the changing environment in business and operations when appropriate. It has been difficult for the media to reflect accurately the real values of technology, whether old or new, against the backdrop of aggressive development and marketing. This has confused the buyers in the marketplace and has detrimentally elongated the procurement process.

Our aim is to attempt to address the industry weakness by assessing in simple – to understand terms the products, and how they are meant to produce beneficial outcomes. Financial IT makes a firm commitment to software vendors that are vital to the success of the future to showcase and examine new products and technologies with deep enquiring analysis. That, at the same time, provides people in financial institutions with the best possible awareness of the latest trends and developments: this should help them reach the business and operational zenith that they aspire too. Financial IT Magazine was first published in 2012.

We cover the latest trends and issues in Transaction Banking, Cloud, Security and Compliance, Data, Trading Systems and Blockchain. The materials of Financial IT come out in the form of periodical print magazine, video interviews and editorial articles featuring FinTech experts, software product reviews as well as market research surveys.

VISIT THE SITE:

https://financialit.net/

Involvation is a consultancy and implementation firm that is focused on improving the supply chain and its management. In doing so, we are driven by possibilities. Our case studies show how we have helped organisations, both large and small, to take the decisive step: the step from the challenge to the result, inspired by the surprising possibilities we identified. Because that is what characterises us: we firmly believe that your supply chain offers potential for improvement. Especially if you are willing to join us in pinpointing the essence of the situation – without becoming distracted by details, symptoms and day-to-day operations.

VISIT THE WEBSITE: https://www.involvation.com/

Solentim is the trusted global leader for solutions to create, isolate, and characterize the highest value cells for the development of new biological medicines, including cell and gene therapies, monoclonal antibodies, vaccines and stem cells. For our customers, which include most of the world’s leading pharmaceutical and biotherapeutics companies, we are the partner of choice for facilitating the highest level of assurance in cell line development for therapeutic protein and viral vector production.

Our customers develop cell and antibody based therapies for a wide range of conditions including lymphomas, cancers, Crohn’s disease, rheumatoid arthritis, high cholesterol and asthma.

Our portfolio of proven and innovative instruments (including VIPS™, Cell Metric^®, Cell Metric^® CLD, ICON™ and STUDIUS™) are designed for single cell cloning and assurance of monoclonality. Combined with enabling reagents  and our unparalleled domain expertise, we transform the speed and efficiency of clonally-derived Master Cell Bank development. Our customers trust in our technology to ensure they are confidently prepared for regulatory review.

Solentim continues to define modern assurance driven workflows for cell based and antibody based biotherapeutics including stem cells, gene therapy and immunotherapy.

VISIT THE WEBSITE: https://www.solentim.com/